VoxCell is a tissue engineering company based in Victoria, BC, Canada. They have developed Canada’s first high-resolution 3D bioprinter, a vascularization algorithm, and their own proprietary bioinks, which can be best described as a bioprinters cartridge.
These three innovations come together to create their vascularized cancer tissue models. VoxCell is selling two avenues of consumables, their proprietary, tissue-specific bioinks and their vascularized cancer tissue models. VoxCell’s tissue models are meant to act as a negative control that can identify which drug or therapeutic candidates will not work in clinical trials. Though their first tissue models are focused on cancer, the technology is not limited to this space: by adjusting their bioinks and cell lines Voxcell aims to assist drug developers accelerate therapeutic development across many diseases.
The mission of VoxCell is to accelerate the development of life-saving therapies, saving time and money for drug developers.